NANOVIBRONIX INC (NAOV) Fundamental Analysis & Valuation
NASDAQ:NAOV • US63008J8844
Current stock price
4.02 USD
-0.29 (-6.73%)
Last:
This NAOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NAOV Profitability Analysis
1.1 Basic Checks
- NAOV had negative earnings in the past year.
- NAOV had a negative operating cash flow in the past year.
- NAOV had negative earnings in each of the past 5 years.
- NAOV had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -10.54%, NAOV is in the better half of the industry, outperforming 60.43% of the companies in the same industry.
- The Return On Equity of NAOV (-13.40%) is better than 64.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| ROIC | N/A |
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 32.06%, NAOV is doing worse than 75.40% of the companies in the same industry.
- In the last couple of years the Gross Margin of NAOV has grown nicely.
- The Profit Margin and Operating Margin are not available for NAOV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.07% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
2. NAOV Health Analysis
2.1 Basic Checks
- NAOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
- NAOV has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for NAOV has been increased compared to 5 years ago.
- NAOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- NAOV has an Altman-Z score of -2.30. This is a bad value and indicates that NAOV is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -2.30, NAOV is not doing good in the industry: 63.10% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.05 indicates that NAOV is not too dependend on debt financing.
- NAOV has a Debt to Equity ratio of 0.05. This is in the better half of the industry: NAOV outperforms 68.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.3 |
ROIC/WACCN/A
WACC8.8%
2.3 Liquidity
- NAOV has a Current Ratio of 1.05. This is a normal value and indicates that NAOV is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of NAOV (1.05) is worse than 88.24% of its industry peers.
- A Quick Ratio of 0.72 indicates that NAOV may have some problems paying its short term obligations.
- NAOV has a worse Quick ratio (0.72) than 87.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.72 |
3. NAOV Growth Analysis
3.1 Past
- NAOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.01%, which is quite impressive.
- NAOV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.41%.
- The Revenue has been growing by 37.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)39.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.68%
Revenue 1Y (TTM)-18.41%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%92.02%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. NAOV Valuation Analysis
4.1 Price/Earnings Ratio
- NAOV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. NAOV Dividend Analysis
5.1 Amount
- No dividends for NAOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NAOV Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:NAOV (12/11/2025, 8:00:01 PM)
4.02
-0.29 (-6.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2025-11-14
Earnings (Next)03-30 2026-03-30
Inst Owners0.54%
Inst Owner Change992.81%
Ins Owners0%
Ins Owner Change0%
Market Cap4.38M
Revenue(TTM)2.69M
Net Income(TTM)-5.42M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.87 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-83.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.61
FCFYN/A
OCF(TTM)-5.61
OCFYN/A
SpS2.15
BVpS37.13
TBVpS-3.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.07% | ||
| FCFM | N/A |
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
F-Score2
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 2.36% | ||
| Cap/Sales | 0.38% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | -2.3 |
F-Score2
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.41%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%92.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-212.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.63%
OCF growth 3YN/A
OCF growth 5YN/A
NANOVIBRONIX INC / NAOV Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NANOVIBRONIX INC (NAOV) stock?
ChartMill assigns a fundamental rating of 2 / 10 to NAOV.
Can you provide the valuation status for NANOVIBRONIX INC?
ChartMill assigns a valuation rating of 0 / 10 to NANOVIBRONIX INC (NAOV). This can be considered as Overvalued.
Can you provide the profitability details for NANOVIBRONIX INC?
NANOVIBRONIX INC (NAOV) has a profitability rating of 2 / 10.